08.07.2022
The Discovery of new aging mechanisms was recently published in the journal "Nature" by a research group coordinated by Stefano Piccolo, professor of the Department of Molecular Medicine at the University of Padua and IFOM (Foundation Institute of Molecular Oncology)
06.07.2022
Thanks to a collaboration between the Veneto Institute of Molecular Medicine (VIMM) and the University of Padua a study shows new features identifying the evolution and subtypes of a rare form of leukemia more precisely
04.07.2022
According to the a new study published in the Journal of AffectiveDisorders those who became ill with COVID-19 experienced significantly more depressive symptoms than healthy subjects, even after recovery, and displayed alterations in the local functional connectivity in the temporo -parietal junction
30.06.2022
On June 30, 2022, the University of Padua hosts a delegation from Monash University, a prestigious Australianinstitute of higher education (57th according to the 2023 QS Ranking agency), with which the University of Padua has recently begun a strategic partnership.
29.06.2022
An international research group from the National Institute of Astrophysics (INAF) and the University of Padua share the TOI-1807b exoplanet discovery, one of the few planets to have a period of revolution around its star in less than one day and the youngest ultra-short period (USP) planet ever discovered
28.06.2022
A research, realized also with the collaboration of the University of Padua, proposes the theory of brain criticality to explain brain-behaviour relationships in neurological patients
27.06.2022
Final results and ranking list of assigned fellowships for UNIPhD Doctoral Programme are now available.
14.06.2022
The National Research Council’s (Cnr) charter for the “Developing Gene Therapy and Medicines with RNA Technology” foundation was signed on June 8 at the University of Padua. The foundation aims to create and renew research infrastructures and laboratories, including private entities, to develop programs that support entrepreneurial initiatives with sophisticated technological abilities through start-ups and spin-off research programs that enhance specific research results
11.06.2022
Researchers from the Veneto Institute of Molecular Medicine (VIMM) and the University of Padua focused on hypocellular myelodysplastic syndromes (h-MDS) that represent a rare subgroup of MDS. They thus identified the clinical features and molecular markers associated with a longer life expectancy in patients with this disease.
10.06.2022
As one of the most authoritative and internationally followed agencies in the field of academic evaluations, QS World University Ranking results have placed the University of Padua among the top 250 universities in the world
